Ion Beam Applications (IOBC.F) Stock Overview
Designs, produces, and markets solutions for cancer diagnosis and treatments, serious illnesses, and industrial applications in Belgium, the United States, China, Germany, and India. More details
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 4/6 |
| Past Performance | 3/6 |
| Financial Health | 3/6 |
| Dividends | 2/6 |
IOBC.F Community Fair Values
Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.
Join community and earn perks
Ion Beam Applications SA Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | €18.30 |
| 52 Week High | €20.10 |
| 52 Week Low | €11.45 |
| Beta | 1.23 |
| 1 Month Change | -5.18% |
| 3 Month Change | 1.95% |
| 1 Year Change | 31.56% |
| 3 Year Change | 22.00% |
| 5 Year Change | 2.23% |
| Change since IPO | 250.57% |
Recent News & Updates
Recent updates
Shareholder Returns
| IOBC.F | US Medical Equipment | US Market | |
|---|---|---|---|
| 7D | -4.2% | -1.0% | -1.4% |
| 1Y | 31.6% | -21.8% | 16.4% |
Return vs Industry: IOBC.F exceeded the US Medical Equipment industry which returned -21.8% over the past year.
Return vs Market: IOBC.F exceeded the US Market which returned 16.4% over the past year.
Price Volatility
| IOBC.F volatility | |
|---|---|
| IOBC.F Average Weekly Movement | n/a |
| Medical Equipment Industry Average Movement | 8.4% |
| Market Average Movement | 7.1% |
| 10% most volatile stocks in US Market | 16.3% |
| 10% least volatile stocks in US Market | 3.2% |
Stable Share Price: IOBC.F's share price has been volatile over the past 3 months compared to the US market.
Volatility Over Time: Insufficient data to determine IOBC.F's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1986 | 2,039 | Olivier Legrain | www.iba-worldwide.com |
Ion Beam Applications SA designs, produces, and markets solutions for cancer diagnosis and treatments, serious illnesses, and industrial applications in Belgium, the United States, China, Germany, and India. It operates through four segments, Clinical Proton Therapy; Clinical Dosimetry; IBA Technologies; and IBA Corporate. The company develops ConformalFLASH, a novel technique using the proton Bragg peak; DynamicARC, a technique that allows dynamic spot scanning irradiation and energy switching while the gantry is rotating; Proteus ONE, a compact proton therapy system transforming cancer treatment; Proteus PLUS, a proton therapy solution for cancer centers; and dosimetry solutions that includes radiation therapy; medical imaging; and QUASAR that offers a portfolio of sophisticated phantoms supporting MR guided radiation therapy, motion management, surface guided radiation therapy, geometric distortion analysis, and machine targeting solutions.
Ion Beam Applications SA Fundamentals Summary
| IOBC.F fundamental statistics | |
|---|---|
| Market cap | US$532.94m |
| Earnings (TTM) | US$14.49m |
| Revenue (TTM) | US$705.63m |
Is IOBC.F overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| IOBC.F income statement (TTM) | |
|---|---|
| Revenue | €620.18m |
| Cost of Revenue | €420.56m |
| Gross Profit | €199.62m |
| Other Expenses | €186.88m |
| Earnings | €12.73m |
Last Reported Earnings
Dec 31, 2025
Next Earnings Date
Aug 27, 2026
| Earnings per share (EPS) | 0.44 |
| Gross Margin | 32.19% |
| Net Profit Margin | 2.05% |
| Debt/Equity Ratio | 68.8% |
How did IOBC.F perform over the long term?
See historical performance and comparisonDividends
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2026/07/23 23:42 |
| End of Day Share Price | 2026/07/23 00:00 |
| Earnings | 2025/12/31 |
| Annual Earnings | 2025/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Ion Beam Applications SA is covered by 10 analysts. 4 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Tim Heirwegh | BNP Paribas |
| Laura Roba | Degroof Petercam |
| Frank Claassen | Degroof Petercam |